期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

不同剂量丙种球蛋白静脉注射治疗川崎病疗效观察 被引量：2

暂未订购
导出
摘要 目的探讨不同剂量丙种球蛋白静脉注射对川崎病的疗效。方法回顾性分析40例川崎病用不同剂量丙种球蛋白静脉注射联合阿斯匹林的治疗情况。结果联合阿斯匹林治疗组较用丙种球蛋白400mg·kg-1·d-1静脉注射,连用2天,联合阿斯匹林治疗组在热程及住院时间上明显减少,用丙种球蛋白400mg·kg-1·d-1,连用4～5天,而对减少心血管损伤发生率无明显差异。结论在明确川崎病后用阿斯匹林治疗的同时应立即联合大剂量静脉丙种球蛋白治疗。
作者 曾绮丹 李绍锦
机构地区 浙江省瑞安市人民医院儿科
出处 《中国现代医药杂志》 2006年第9期28-29,共2页 Modern Medicine Journal of China
关键词 川崎病 阿斯匹林 丙种球蛋白
分类号 R725.4 [医药卫生—儿科]
  • 相关文献

参考文献3

  • 1[2]Furukawa S,Matsubara T,Umezawa,et al.Serum levels of P60 Solu ble tumor necrosis factor receptor during acute Kawaaski disease.JPediara,1994,24:721-725
  • 2阿日根,高娃,刘春华,李红.川畸病的诊治进展[J].医学综述,2001,7(3):167-170. 被引量：6
  • 3[4]Terai M,Shulman ST.Prevalence of coronary artery abnormalities in ka2 wasaki disease is highly dependent on gammaglobulin dose but indepen2dent of salicylate dose.J Pediatr,1997,131:888-893

二级参考文献10

  • 1[1]Niwa K,Aotsuka H,Hamada H,et al. Thrombocytopenta:A risk factor for acute myocardial infarction during the acute Phase of Kawasaki disease. coron Artery Dis, 1995,6: 857-864
  • 2[2]Choi IH, Chwae YJ, Shim WP, et al. Clonal expansion of CD+8 T cells in Kawasaki disease. J Immunol, 1997,159:481-486
  • 3[3]Kato H, Sugimura T, Akagi T, et al. Long term consequences of kawasaki disease. Circulation, 1994,94:1279-1285
  • 4[4]Akagi T, Kato H, Inoue O, et al. Valvular heart disease in kawasaki Syndrome. Incidence and natural history. Am Heart J, 1990,120: 366-372
  • 5[5]Burns JC, Shike H, Gordon JB, et al. Sequelae of kawasaki disease in adolescents and young adults. J Am Coll Cardiol, 1996,28: 253-257
  • 6[6]Sawaji Y, Haneda N,Yamaguchi S, et al. Risk factors for coronary lesions in acute kawasaki disease. In Kato H (ed): Kawasaki Disease. Elsevier Science, Amsterdam, The Netherlands, 1995,377-380
  • 7[7]Rowley AH, Eckerley CA, Jack HM, et al. IgA plasma cells in vascular tissure of patients with kawasaki syndrome. J Immunol, 1997, 159: 5946-5955
  • 8[8]Terai M, Shulman ST. Prevalence of coronary artery abnormalities in kawasaki disease is highly dependent on gammaglobulin dose but independent of salicylate dose. J Pediatr, 1997,131: 888-893
  • 9[9]Sundel RP, Burns JC, Baker A, et al. Gamma globulin re treatment in kawasaki disease. J Pediatr, 1993,123:657-659
  • 10[12]Noto N, Aynsawa M, Karasawa K, et al. Dobutamine stress echocardio graphy for detection of coronary artery stenosis in children with kawasaki disease. J Am Coll Cardiol, 1996,27:1251-1256

共引文献5

同被引文献18

  • 1陈玺,徐尔迪,肖延风.不同剂量的丙种球蛋白对川崎病冠状动脉损害的预防作用[J].中国全科医学,2009,12(6):493-495. 被引量：18
  • 2陆智俊,吴夕芳.不同剂量丙种球蛋白治疗川崎病疗效观察[J].实用中西医结合临床,2004,4(4):30-31. 被引量：2
  • 3农淑萍,李凯红,刘喜.不同剂量丙种球蛋白治疗川崎病34例疗效分析[J].咸宁学院学报（医学版）,2006,20(4):294-294. 被引量：1
  • 4杜忠东.川崎病病因和发病机制研究进展[J].中国实用儿科杂志,2006,21(10):724-726. 被引量：26
  • 5Lee TJ, Kim KH, Chun JK, et al. Low-dose methotrexate thera-py for intravenous immunoglobulin-resistant kawasaki disease[ J ]. Yonsei Med J, 2008,49:714 -718.
  • 6Burns JC, Best BM, Mejias A, et al. Infliximab treatment of in-travenous immunoglobulin-resistant kawasaki disease [ J ]. J Pediatr, 2008, 153 : 833 - 888.
  • 7Furukawa S, Matsubara T, Umezawa Y, et al. Serum levels of P60 Solu- ble tumor necrosis factor receptor during acute Kawaaski disease [ J ]. J Pediatr, 1994,24:721 - 725.
  • 8Terai M, Shulman ST. Prevalence of coronary artery abnormalitiesin ka2 wasaki disease is highly dependent on gammaglobulin dose but inde pen2dent of salicylate dose[ J]. J Pediatr, 1997,131:888 - 893.
  • 9Taubert KA. Epidemiology of Kawasaki dis-ease in theUnited States and worldwide[ J]. Prog Pediatr Cardio,1 1997, 6 : 181 - 185.
  • 10Newburger IW, Taubert KA, Shulman ST,et a. 1 Summary and abstractof the seventh in-ternational kawasaki disease symposium: de-cember 4-7, 2001, Hakone, Japan[J]. Pediatr Res, 2003, 53: 153- 157.

引证文献2

二级引证文献4

中国现代医药杂志
2006年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部